Profiles of immune cells in severe Pseudomonas sepsis
Part of Infections, Lungs & breathing clinical trials.
This study looks at patterns of immune cells in people who are critically ill with sepsis caused by Pseudomonas aeruginosa bacteria. It may help doctors better understand how the immune system responds and improve care for this serious infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 years old
- You are critically ill with sepsis (a whole-body response to infection)
- Lab tests have confirmed Pseudomonas aeruginosa as the cause of the infection
- Your expected survival is at least 24 hours
- You are not currently in another research study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system reacts to sepsis (a severe infection that causes organs to fail) and whether there are lasting effects on health. It may help researchers understand why some people recover well and others don’t.
This study looks at a type of immune cell called 'memory CD8+ T cells' in patients with sepsis, a life-threatening response to infection. The goal is to see if these cells are linked to how severe the sepsis is and the risk of dying. This may help doctors better predict outcomes for people with sepsis.
This study wants to learn how your immune system reacts to a serious infection (like sepsis) in the ICU. By looking at your immune cells, doctors hope to better predict your recovery and find the best treatment for you.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This study looks at different types of sepsis in patients with severe pneumonia. It aims to see how the type of sepsis affects treatment with a common antibiotic called piperacillin/tazobactam.
This study is looking at how the immune system changes in people with sepsis. If you have been diagnosed with sepsis in the last 48 hours, researchers want to better understand your immune response, which could help improve treatments.
Hear when a new Pseudomonas Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.